Keryx Biopharmaceuticals (NASDAQ:KERX)

CAPS Rating: 2 out of 5

A biopharmaceutical company focused on the acquisition, development and commercialization of medically important, novel pharmaceutical products for the treatment of life-threatening diseases, including diabetes and cancer.


Player Avatar pchop123 (80.35) Submitted: 4/24/2013 10:01:47 AM : Underperform Start Price: $8.16 KERX Score: +5.95

only if you believe in the tooth fairy

Featured Broker Partners